Wellmedr advertises compounded GLP-1 treatment from $88 per month, without a separate membership fee. That headline is attractive, but it does not represent a flexible monthly subscription. The lowest rate requires paying $1,056 for a full year of compounded semaglutide in advance.
The platform connects patients with independent clinicians who may prescribe compounded semaglutide or tirzepatide after reviewing an online medical assessment. Medication, shipping, provider oversight and care coaching are generally included.
Our Wellmedr review found potentially competitive bundled pricing and a more structured coaching program than many medication-only services. It also found conflicting renewal and cancellation terms, no centrally published pharmacy list and marketing statements that understate side effects or incorrectly describe compounded products as FDA approved.
Key takeaways
- Monthly plans currently cost $149 for compounded semaglutide and $249 for compounded tirzepatide. The advertised $88 and $158 rates require 12-month prepayment.
- The price generally includes medication, clinical review, shipping, dosage support and care coaching, without a separate membership fee.
- Independent OpenLoop Health clinicians and other provider networks make prescribing decisions. Completing the intake does not guarantee treatment.
- Wellmedr does not accept insurance. State availability is checked during enrollment rather than through a public coverage list.
- Its cancellation policy contains conflicting 48- and 72-hour notice periods and separately states that subscriptions renew every 21 days.
- The FAQ says its medications are FDA approved, while the company’s own footer correctly states that its compounded products are not. This should be corrected.
Wellmedr at a glance
| Category | What we found |
|---|---|
| Care model | Online intake, independent clinician review and home delivery |
| Main treatments | Compounded injectable semaglutide and tirzepatide; compounded oral semaglutide also advertised |
| Monthly prices | $149 for semaglutide; $249 for tirzepatide |
| Lowest advertised rates | $88 and $158 monthly equivalents with annual prepayment |
| Separate membership | None advertised |
| Medication included | Generally yes, when prescribed |
| Insurance | Not accepted |
| Clinical network | OpenLoop Health and other licensed-provider networks |
| Coaching | Certified medical-assistant coaching included |
| Pharmacy disclosure | U.S.-licensed pharmacies referenced, but not named centrally |
| Main concern | Contradictory regulatory, cancellation and side-effect language |
Information checked August 5, 2026. Prices, pharmacy assignments, formulations and policies may change.
How the Wellmedr program works
Patients begin with an online questionnaire covering health history, current medication, weight and treatment goals. An independent licensed clinician reviews the information and determines whether GLP-1 treatment is medically appropriate. A live appointment may be required in some cases, while other evaluations can be completed through electronic forms.
If treatment is approved, the prescription is sent to a pharmacy and shipped to the patient. Wellmedr says most orders leave the pharmacy within one or two business days after approval, followed by approximately three to five business days for standard delivery. Those estimates are not guarantees.
Members can message their provider about side effects and dose changes. The program also includes a certified medical assistant who acts as a care coach. Wellmedr describes an initial coaching session within 14 days and continuing sessions approximately every two weeks, although members can choose a different schedule.
The coaching covers medication use, nutrition, lifestyle habits, sleep and emotional eating. Wellmedr acknowledges that this service does not replace care from a registered dietitian or therapist.
Which medications does Wellmedr offer?
Wellmedr’s main program promotes:
- Weekly compounded semaglutide injections
- Weekly compounded tirzepatide injections
- Daily compounded oral or dissolving semaglutide
- Lower-dose “microdose” GLP-1 plans
These are compounded preparations rather than FDA-approved Wegovy or Zepbound. They are also not FDA-approved generic equivalents of those products. The FDA does not review a compounded drug’s finished formulation for safety, effectiveness or quality before it is dispensed.
The distinction is especially important for Wellmedr’s dissolving tablets. Evidence supporting FDA-approved injectable or oral semaglutide should not automatically be applied to a separately compounded dosage form.
How much does Wellmedr cost?
The live checkout displayed the following prices:
| Plan | Semaglutide | Tirzepatide |
|---|---|---|
| Monthly | $149/month | $249/month |
| Three months | $435 total | $627 total |
| Six months | $720 total | $1,134 total |
| 12 months | $1,056 total | $1,880 total |
The annual plans produce monthly equivalents of $88 for semaglutide and approximately $158 for tirzepatide. The complete amount is due upfront rather than billed at those monthly rates.
Wellmedr says prices remain unchanged as the dose increases. Its checkout also describes medication, free delivery, clinician review and continuing support as included. Consumers should save that checkout disclosure because the refund policy says the exact services, medications and laboratory work covered by a subscription can vary.
Multi-month plans create additional financial risk. Wellmedr says unused months may be refunded on a prorated basis, but it recalculates the refund using the regular non-bundle price. A member who cancels early may therefore lose part of the original discount.
Insurance, laboratory testing and state availability
Wellmedr does not currently accept insurance. HSA or FSA eligibility depends on the patient’s account and plan administrator.
Laboratory testing is not clearly guaranteed as part of every program. The refund policy says a subscription may include laboratory services but that coverage varies. Ask whether testing is required, where it will be performed and whether it creates an additional charge.
The company requires patients to live in a state where services are available, but it does not publish a definitive state-by-state list. Eligibility is confirmed during intake.
Pharmacy transparency remains limited
Wellmedr says medications are dispensed by accredited or licensed U.S. pharmacies. However, we did not find a central public list identifying the pharmacies currently used for weight-loss prescriptions.
“FDA-registered” or “FDA-regulated” does not mean the FDA has approved an individual pharmacy’s compounded medication. Patients should ask for the dispensing pharmacy’s legal name, address, state license and authorization to ship into their state.
This is particularly relevant because the FDA warned in June 2026 that fraudulent compounded GLP-1 products have appeared with nonexistent pharmacy names or labels naming pharmacies that did not prepare the product.
Marketing claims require caution
Wellmedr’s main weight-loss page promotes treatment “without nausea or harsh side effects,” while its microdosing page uses “zero side effects” language. Those statements are too absolute for prescription medication.
Its FAQ also states that the offered medications are FDA approved. That directly conflicts with Wellmedr’s footer disclosure that its compounded products are not approved or evaluated by the FDA.
The company advertises a 90-day money-back guarantee, but the published refund policy does not clearly define the required adherence, documentation or minimum result. The guarantee should not influence enrollment unless Wellmedr supplies its complete written conditions.
Cancellation and refund terms
Wellmedr’s refund page contains several overlapping policies:
- One section says cancellation must occur at least 48 hours before renewal.
- Another requires at least 72 hours’ notice.
- The same page states that subscriptions renew every 21 days, despite other materials describing monthly plans.
- Once an intake has been approved or sent for clinical or pharmacy processing, the current order may become nonrefundable even if it has not shipped.
The safest approach is to cancel through the account and by email at least 72 hours before the earliest possible renewal date, then retain written confirmation.
Applicants found medically ineligible before a prescription is issued should receive a full refund.
Potential benefits
Wellmedr may appeal because it offers:
- Medication, shipping and support under one advertised price
- No separate membership fee
- Lower rates for longer commitments
- Dose-independent pricing
- Provider messaging and continuing monitoring
- Structured care coaching rather than prescription fulfillment alone
- A refund when the clinician declines treatment before prescribing
Meaningful limitations
The principal drawbacks are:
- Compounded products are not FDA approved
- The lowest prices require substantial advance payment
- Pharmacies are not identified prominently
- Cancellation and renewal terms conflict
- Insurance is not accepted
- Laboratory coverage is unclear
- Some marketing minimizes recognized medication risks
- The FDA-approval statement in the FAQ is inaccurate
- Continuing access may be affected by tightening federal compounding rules
The FDA considers the national semaglutide and tirzepatide shortages resolved. Routine production of compounded products that are essentially copies of available approved drugs is now more restricted, although individualized compounding can remain permissible under specific legal conditions.
Safety and eligibility considerations
Common adverse effects associated with FDA-approved semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation and abdominal discomfort. Their labeling also warns about pancreatitis, gallbladder problems, dehydration-related kidney injury, severe gastrointestinal reactions and serious hypersensitivity.
Wegovy and Zepbound carry boxed warnings concerning thyroid C-cell tumors observed in animals. They are contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Pregnancy, diabetes medication and significant digestive disease also require individualized clinical review.
Compounded vials introduce an additional possibility of dosing confusion because concentrations and syringe markings may differ. The FDA has received reports of overdoses associated with patients or providers miscalculating compounded semaglutide doses.
Who may find Wellmedr worth considering?
Wellmedr may be worth considering for adults who expect to pay cash, accept the limitations of compounded medication and want coaching included without a separate membership.
It may not suit people who want only FDA-approved treatment, require insurance support, prefer a clearly named pharmacy before checkout or are uncomfortable prepaying for six or 12 months.
Questions to ask before enrolling
- Which pharmacy will prepare my prescription?
- What exact ingredients and concentration will I receive?
- Why is a compounded formulation appropriate for my individual needs?
- What date will the subscription renew?
- Is my billing cycle 21 days or one calendar month?
- Which cancellation deadline applies?
- What laboratory testing is required and included?
- What are the complete 90-day guarantee conditions?
- Does the price remain fixed at every dosage?
- What refund applies if I stop a prepaid plan early?
Final assessment
Wellmedr’s strongest features are straightforward bundled pricing, no separate membership fee and included care coaching. Its monthly prices are competitive, while the annual plans lower the effective cost further for people prepared to make a substantial upfront commitment.
The program’s public documentation needs improvement. Cancellation and renewal rules conflict, partner pharmacies are not named centrally, side-effect claims are overstated and the FAQ incorrectly labels compounded medications as FDA approved.
Wellmedr may be a reasonable cash-pay option after a licensed clinician confirms eligibility and the patient receives clear written information about the formulation, pharmacy, billing cycle, cancellation deadline and guarantee. The $88 headline should not be considered independently of the $1,056 annual commitment or the limitations of compounded treatment.
Frequently asked questions
Is Wellmedr legitimate?
Wellmedr is an identifiable telehealth platform operated by Wellmedr LLC. It connects patients with independent licensed clinicians, including providers through OpenLoop Health, and says prescriptions are filled by U.S. pharmacies. Legitimacy should still be verified at the prescription level by confirming the clinician and pharmacy.
Is Wellmedr medication FDA approved?
Its principal compounded semaglutide and tirzepatide products are not FDA approved. Wellmedr’s FAQ currently says otherwise, but the company’s fuller disclosure correctly states that the compounded medications have not been evaluated or approved by the FDA.
Does Wellmedr really cost $88 per month?
The $88 figure is the monthly equivalent of a $1,056 prepaid annual semaglutide plan. The flexible monthly semaglutide option costs $149. Tirzepatide costs $249 monthly or $1,880 for a year, equivalent to approximately $158 per month.
Does Wellmedr accept insurance?
No. Wellmedr currently operates as a cash-pay service. HSA or FSA reimbursement may depend on the patient’s specific account rules.
Can I cancel Wellmedr at any time?
Future renewals can be cancelled, but Wellmedr publishes conflicting notice periods of 48 and 72 hours. Current orders become nonrefundable after clinical or pharmacy processing begins.
Does Wellmedr require laboratory testing?
Its public materials do not identify a universal laboratory requirement. Testing may depend on the clinician and patient’s history, and the refund policy says included laboratory services can vary.
